Skip to main content

Table 1 Grouping for experimental animals

From: Protective effects of dexmedetomidine on cerebral ischemia/reperfusion injury via the microRNA-214/ROCK1/NF-κB axis

Group (n = 10)

Surgerical procedures

sham

Procedures for anesthesia were the same as that for the MCAO group, except for the occlusion of middle cerebral artery

DEX

Based on the sham group, DEX was intravenously administered at a loading dose of 1 μg/kg at the very beginning of the surgery, and was then administered at 0.05 μg/kg/min for the next two hours

MCAO

MCAO modeling

MCAO + DEX

Simultaneous treatment of MCAO modeling and DEX

NC inhibitor/miR-214 inhibitor

Based on the operation of MCAO + DEX, NC inhibitor/miR-214 inhibitor (80 nM) with invivofectamine was administered via intracerebroventricular infusion half an hour before surgery

oe-NC/oe-ROCK1

Based on the operation of MCAO + DEX, oe-NC/oe-ROCK1 (100 nM) with invivofectamine was administered via intracerebroventricular infusion half an hour before surgery

  1. Plasmids of miR-214 inhibitor, oe-ROCK1 and the matched NC were purchased from GenePharma (Shanghai, China)
  2. Notes: DEX Dexmedetomidine, MCAO Middle cerebral artery occlusion, ROCK1 Rho-associated kinase 1, miR-214 MicroRNA-214, NC Negative control